283 related articles for article (PubMed ID: 35350597)
21. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
Levet S; Ciais D; Merdzhanova G; Mallet C; Zimmers TA; Lee SJ; Navarro FP; Texier I; Feige JJ; Bailly S; Vittet D
Blood; 2013 Jul; 122(4):598-607. PubMed ID: 23741013
[TBL] [Abstract][Full Text] [Related]
23. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
[TBL] [Abstract][Full Text] [Related]
24. Bmp9 regulates Notch signaling and the temporal dynamics of angiogenesis via Lunatic Fringe.
Ristori T; Thuret R; Hooker E; Quicke P; Lanthier K; Ntumba K; Aspalter IM; Uroz M; Herbert SP; Chen CS; Larrivée B; Bentley K
bioRxiv; 2023 Sep; ():. PubMed ID: 37808725
[TBL] [Abstract][Full Text] [Related]
25. BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.
Young K; Tweedie E; Conley B; Ames J; FitzSimons M; Brooks P; Liaw L; Vary CP
PLoS One; 2015; 10(4):e0122892. PubMed ID: 25909848
[TBL] [Abstract][Full Text] [Related]
26. Specificity and structure of a high affinity activin receptor-like kinase 1 (ALK1) signaling complex.
Townson SA; Martinez-Hackert E; Greppi C; Lowden P; Sako D; Liu J; Ucran JA; Liharska K; Underwood KW; Seehra J; Kumar R; Grinberg AV
J Biol Chem; 2012 Aug; 287(33):27313-25. PubMed ID: 22718755
[TBL] [Abstract][Full Text] [Related]
27. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
[TBL] [Abstract][Full Text] [Related]
28. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
[TBL] [Abstract][Full Text] [Related]
29. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
[TBL] [Abstract][Full Text] [Related]
30. A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10.
Ruiz S; Zhao H; Chandakkar P; Chatterjee PK; Papoin J; Blanc L; Metz CN; Campagne F; Marambaud P
Sci Rep; 2016 Nov; 5():37366. PubMed ID: 27874028
[TBL] [Abstract][Full Text] [Related]
31. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro.
Muñoz-Félix JM; Cuesta C; Perretta-Tejedor N; Subileau M; López-Hernández FJ; López-Novoa JM; Martínez-Salgado C
Cell Signal; 2016 Sep; 28(9):1252-1261. PubMed ID: 27208502
[TBL] [Abstract][Full Text] [Related]
32. Exogenous BMP9 promotes lung fibroblast HFL-1 cell activation via ALK1/Smad1/5 signaling
Wang Y; Sima X; Ying Y; Huang Y
Exp Ther Med; 2021 Jul; 22(1):728. PubMed ID: 34007337
[TBL] [Abstract][Full Text] [Related]
33. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
34. High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells.
Andersson-Rusch C; Liu B; Quist-Løkken I; Upton PD; Olsen OE; Hella H; Yang X; Tong Z; Morrell NW; Holien T; Li W
Sci Rep; 2023 Apr; 13(1):6639. PubMed ID: 37095146
[TBL] [Abstract][Full Text] [Related]
35. Emerging role of bone morphogenetic proteins in angiogenesis.
David L; Feige JJ; Bailly S
Cytokine Growth Factor Rev; 2009 Jun; 20(3):203-12. PubMed ID: 19502096
[TBL] [Abstract][Full Text] [Related]
36. ALK1-Fc inhibits multiple mediators of angiogenesis and suppresses tumor growth.
Mitchell D; Pobre EG; Mulivor AW; Grinberg AV; Castonguay R; Monnell TE; Solban N; Ucran JA; Pearsall RS; Underwood KW; Seehra J; Kumar R
Mol Cancer Ther; 2010 Feb; 9(2):379-88. PubMed ID: 20124460
[TBL] [Abstract][Full Text] [Related]
37. Role of soluble endoglin in BMP9 signaling.
Lawera A; Tong Z; Thorikay M; Redgrave RE; Cai J; van Dinther M; Morrell NW; Afink GB; Charnock-Jones DS; Arthur HM; Ten Dijke P; Li W
Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17800-17808. PubMed ID: 31431534
[TBL] [Abstract][Full Text] [Related]
38. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
[TBL] [Abstract][Full Text] [Related]
39. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.
Li H; Zhao D; Wang S; Ding J; Zhao L
Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860
[TBL] [Abstract][Full Text] [Related]
40. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
Ayuso-Íñigo B; Méndez-García L; Pericacho M; Muñoz-Félix JM
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
